Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Elan | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Elan

Kelly Martin will step down from his role as chief executive officer of Elan Corp. on May 1, 2012.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kelly Martin will step down from his role as chief executive officer of Elan Corp. on May 1, 2012. Mr. Martin will then serve as the board’s executive adviser through January 31, 2013. According to a company statement, the arrangement allows Mr. Martin, who had an open-ended agreement, and company directors, to run “a comprehensive succession process.”

Elan’s chairman, Kyran McLaughlin, said, “Elan’s Board is committed to long term leadership succession planning as it is an important part of good governance policies. The amendments to Kelly’s employment arrangements are a necessary and desirable part of this commitment. On behalf of Elan’s Board, we recognize the significant contribution Kelly has made to the company since 2003 and look forward to the company benefitting from Kelly’s continued leadership and direction in the coming years.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters